Deans G T, Spence R A, Johnston G W
Ulster Med J. 1985 Oct;54(2):155-9.
Fourteen patients in whom peritoneovenous shunts were inserted for intractable ascites or malignancy were reviewed.Reduction in ascites was obtained in all patients by the time of discharge with significant diuresis and weight loss. Significant decrease in haemoglobin, packed cell volume, platelet count and prothrombin time also occurred. Coagulation studies were abnormal in 60 per cent of patients in whom they were performed with bruising or detectable bleeding occurring in 28.5 per cent of all patients. Late blockage of the shunt occurred in five patients and was less frequent in Denver than in Le Veen type shunts.Cumulative mortality one month after shunt insertion was 28.5 per cent and at one year was 78.5 per cent reflecting the severity of the underlying disease.Peritoneovenous shunting should be reserved for palliation in patients resistant to full conventional medical therapy.
对14例因顽固性腹水或恶性肿瘤而植入腹腔静脉分流管的患者进行了回顾性研究。所有患者出院时腹水均有减少,伴有显著的利尿和体重减轻。血红蛋白、红细胞压积、血小板计数和凝血酶原时间也显著下降。60%接受凝血研究的患者结果异常,28.5%的患者出现瘀伤或可检测到的出血。5例患者出现分流管晚期堵塞,丹佛型分流管的堵塞发生率低于Le Veen型分流管。分流管植入后1个月的累积死亡率为28.5%,1年时为78.5%,这反映了基础疾病的严重程度。腹腔静脉分流术应仅用于对充分的传统药物治疗无效的患者的姑息治疗。